Skip to main content

Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.

Publication ,  Journal Article
Jia, M; Zhu, M; Wang, M; Sun, M; Qian, J; Ding, F; Chang, J; Wei, Q
Published in: Oncotarget
May 3, 2016

The JNK and P38α pathways play a crucial role in tissue homeostasis, apoptosis and autophagy under genotoxic stresses, but it is unclear whether single nucleotide polymorphisms (SNPs) of genes in these pathways play a role in platinum-based chemotherapy-induced toxicities in patients with advanced non-small cell lung cancer (NSCLC). We genotyped 11 selected, independent, potentially functional SNPs of nine genes in the JNK and P38α pathways in 689 patients with advanced NSCLC treated with platinum-combination chemotherapy regimens. Associations between these SNPs and chemotherapy toxicities were tested in a discovery group of 345 patients and then validated in a replication group of 344 patients. In both discovery and validation groups as well as their pooled analysis, carriers of GADD45B rs2024144T variant allele had a significantly higher risk for severe hematologic toxicity and carriers of MAPK14 rs3804451A variant allele had a significantly higher risk for both overall toxicity and gastrointestinal toxicity. In addition, carriers of GADD45A rs581000C had a lower risk of anemia, while carriers of GADD45B rs2024144T had a significantly higher risk for leukocytopenia or agranulocytosis. The present study provides evidence that genetic variants in genes involved in the JNK and P38α pathways may predict platinum-based chemotherapy toxicity outcomes in patients with advanced NSCLC. Larger studies of other patient populations are needed to validate our findings.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Oncotarget

DOI

EISSN

1949-2553

Publication Date

May 3, 2016

Volume

7

Issue

18

Start / End Page

25291 / 25303

Location

United States

Related Subject Headings

  • Young Adult
  • Polymorphism, Single Nucleotide
  • Nuclear Proteins
  • Mitogen-Activated Protein Kinase 14
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans
  • Genotype
  • Genetic Predisposition to Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jia, M., Zhu, M., Wang, M., Sun, M., Qian, J., Ding, F., … Wei, Q. (2016). Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer. Oncotarget, 7(18), 25291–25303. https://doi.org/10.18632/oncotarget.8052
Jia, Ming, Meiling Zhu, Mengyun Wang, Menghong Sun, Ji Qian, Fei Ding, Jianhua Chang, and Qingyi Wei. “Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.Oncotarget 7, no. 18 (May 3, 2016): 25291–303. https://doi.org/10.18632/oncotarget.8052.
Jia, Ming, et al. “Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.Oncotarget, vol. 7, no. 18, May 2016, pp. 25291–303. Pubmed, doi:10.18632/oncotarget.8052.
Jia M, Zhu M, Wang M, Sun M, Qian J, Ding F, Chang J, Wei Q. Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer. Oncotarget. 2016 May 3;7(18):25291–25303.

Published In

Oncotarget

DOI

EISSN

1949-2553

Publication Date

May 3, 2016

Volume

7

Issue

18

Start / End Page

25291 / 25303

Location

United States

Related Subject Headings

  • Young Adult
  • Polymorphism, Single Nucleotide
  • Nuclear Proteins
  • Mitogen-Activated Protein Kinase 14
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans
  • Genotype
  • Genetic Predisposition to Disease